3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
6
Phase 3
2
Phase 4
1
Phase 1
1
Status
Completed
51
Terminated
11
Active not recruiting
11
Unknown
9
Recruiting
5
Withdrawn
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
2
Interventions
Cisplatin
22
Carboplatin
15
Radiotherapy
13
Paclitaxel
11
Gemcitabine
10
Rituximab
9
Fluorouracil
9
Drug Therapy
6
Dexamethasone
5
Cyclophosphamide
5
Capecitabine
5
Bevacizumab
5
Vinorelbine
4
Pemetrexed
4
Nivolumab
4
Methotrexate
4
Etoposide
4
Docetaxel
4
Bendamustine Hydrochloride
4
spartalizumab
3
pertuzumab
3
pembrolizumab
3
fludarabine
3
Vincristine
3
Trastuzumab
3
Surgical Procedures, Operative
3
Standard of Care
3
Prednisone
3
Oxaliplatin
3
Lenalidomide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Withdrawn
×
Goserelin
×
Clear all
NCT03658213
2021-05-10
LARES
AstraZeneca
Phase 3
Withdrawn
NCT00888082
2010-12-10
PROOF
AstraZeneca
Phase 3
Withdrawn
102 enrolled